-
RedHill Biopharma, Cosmo Pharma In Manufacturing Pact for Movantik, RHB-204
Thursday, February 18, 2021 - 2:00pm | 265RedHill Biopharma Ltd (NASDAQ: RDHL) has announced agreements with Cosmo Pharmaceuticals NV to manufacture RedHill's largest selling product in the U.S., Movantik, and RHB-204, currently in a Phase 3 U.S. study as a stand-alone, first-line orally-administered treatment for...